Digestive & Intestinal Remedies (Pharmacies) - Burkina Faso

  • Burkina Faso
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$7.32m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.59%, resulting in a market volume of US$7.92m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.31 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Burkina Faso has been experiencing significant growth in recent years.

Customer preferences:
Burkina Faso, like many other countries, has seen a rise in the demand for digestive and intestinal remedies. This can be attributed to several factors, including changes in lifestyle and dietary habits. As people adopt more Westernized diets and experience increased stress levels, digestive issues such as indigestion and constipation have become more common. Additionally, the aging population in Burkina Faso has contributed to the growing demand for these remedies, as older individuals are more prone to digestive problems.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Burkina Faso is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious about the ingredients used in the products they consume and are seeking natural alternatives to traditional pharmaceutical remedies. This has led to a rise in the demand for herbal supplements and remedies that are believed to have fewer side effects. Another trend in the market is the growing availability of digestive and intestinal remedies in pharmacies across the country. Previously, these products were primarily available in specialized health stores or through traditional medicine practitioners. However, with the expansion of the pharmacy sector in Burkina Faso, consumers now have easier access to a wider range of digestive and intestinal remedies. This increased accessibility has contributed to the overall growth of the market.

Local special circumstances:
Burkina Faso, like many other countries in the region, has a high prevalence of gastrointestinal diseases. This can be attributed to factors such as poor sanitation and hygiene practices, limited access to clean water, and inadequate healthcare infrastructure. As a result, the demand for digestive and intestinal remedies is particularly high in Burkina Faso. Additionally, traditional medicine plays a significant role in the healthcare system of Burkina Faso. Many individuals rely on traditional remedies and practices to treat digestive issues. This has created a unique market dynamic, where traditional and modern remedies coexist.

Underlying macroeconomic factors:
The growth of the Digestive & Intestinal Remedies market in Burkina Faso is also influenced by several macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income. This has allowed consumers to allocate more of their budget towards healthcare and wellness products, including digestive and intestinal remedies. Furthermore, the government of Burkina Faso has been investing in the healthcare sector, including the expansion of healthcare facilities and the improvement of healthcare services. This has contributed to the overall growth of the market, as consumers have better access to healthcare and are more likely to seek remedies for their digestive issues. In conclusion, the Digestive & Intestinal Remedies market in Burkina Faso is growing due to changing customer preferences, including the demand for natural remedies, increased availability of products in pharmacies, and the high prevalence of gastrointestinal diseases. Local special circumstances, such as the reliance on traditional medicine, also play a role in shaping the market. Additionally, underlying macroeconomic factors, such as economic growth and government investment in healthcare, contribute to the overall development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)